North America Drug Screening Market - by Test Sample (Urine, Blood, Hair and Saliva) by condition (Unconsciousness, Panic Attack, Chest Pain, Drug Allergies and Others)- Forecast to 2032

Table of Contents
1 INTRODUCTION

1.1 DEFINITION

1.2 SCOPE OF STUDY

1.2.1 RESEARCH OBJECTIVE

1.2.2 ASSUMPTIONS & LIMITATIONS

1.2.2.1 ASSUMPTIONS

1.2.2.2 LIMITATIONS

1.3 MARKET STRUCTURE:

2 RESEARCH METHODOLOGY

2.1 RESEARCH PROCESS:

2.2 PRIMARY RESEARCH

2.3 SECONDARY RESEARCH:

3 MARKET DYNAMICS

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 MACROECONOMIC INDICATORS

4 MARKET FACTOR ANALYSIS

4.1 PORTERS FIVE FORCES MODEL

4.2 BARGAINING POWER OF SUPPLIERS

4.3 BARGAINING POWER OF BUYERS

4.4 THREAT OF NEW ENTRANTS

4.5 THREAT OF SUBSTITUTES

4.6 INTENSITY OF RIVALRY

5 NORTH AMERICA DRUG SCREENING MARKET, BY TEST SAMPLE

5.1 HAIR

5.2 BLOOD

5.3 URINE

5.4 SALIVA

6. NORTH AMERICA DRUG SCREENINGMARKET, BY CONDITION

6.1 UNCONSCIOUSNESS

6.2 PANIC ATTACK

6.3 CHEST PAIN

6.4 BREATHING PROBLEM

6.5 SEIZURES

6.6 ORGAN TRANSPLANT

6.7 PAIN MANAGEMENT

6.8 DRUG ALLERGIES

7. NORTH AMERICA DRUG SCREENINGMARKET, BY REGION

7.1 INTRODUCTION

7..2 NORTH AMERICA

7.2.1. U.S

7.2.2 CANADA

8. COMPETITIVE LANDSCAPE

8.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS

8.1.1 STRATEGIC PARTNERSHIP

8.1.2 MERGER & ACQUISITION

9 COMPANY PROFILE

9.1 ALERE TOXICOLOGY

9.1.1 OVERVIEW

9.1.2 PRODUCT OVERVIEW

9.1.3 FINANCIALS

9.1.4 KEY DEVELOPMENTS

9.2 EXPRESS DIAGNOSICS

9.2.1 OVERVIEW

9.2.2 PRODUCT OVERVIEW

9.2.3 FINANCIALS

9.2.4 KEY DEVELOPMENTS

9.3 KGaA

9.3.1 OVERVIEW

9.3.2 PRODUCT OVERVIEW

9.3.3 FINANCIALS

9.3.4 KEY DEVELOPMENT

9.4 LABORATORY CORPORATION OF AMERICA

9.4.1 OVERVIEW

9.4.2 PRODUCT OVERVIEW

9.4.3 FINANCIALS

9.4.4 KEY DEVELOPMENTS

9.5 MPD INC.

9.5.1 OVERVIEW

9.5.2 PRODUCT OVERVIEW

9.5.3 FINANCIALS

9.5.4 KEY DEVELOPMENTS

9.6 QUEST DIAGNOSTICS

9.6.1 OVERVIEW

9.6.2 PRODUCT OVERVIEW

9.6.3 FINANCIALS

9.6.4 KEY DEVELOPMENTS

9.7 SIEMENS

9.7.1 OVERVIEW

9.7.2 PRODUCT OVERVIEW

9.7.3 FINANCIALS

9.7.4 KEY DEVELOPMENTS

9.8 ROCHE DIAGNOSTICS

9.8.1 OVERVIEW

9.8.2 PRODUCT OVERVIEW

9.8.3 FINANCIALS

9.8.4 KEY DEVELOPMENTS

9.9 OTHERS